Skip to main content

Market Overview

46 Stocks Moving In Monday's Mid-Day Session

Share:

Gainers

  • American Electric Technologies, Inc (NASDAQ: AETI) shares jumped 187.4 percent to $1.15 after the company disclosed that its joint venture, BOMAY, received a major order for drilling rig control systems.
  • TESARO Inc (NASDAQ: TSRO) surged 58.8 percent to $73.64 after GlaxoSmithKline plc (NYSE: GSK) announced plans to acquire the company for $75 per share in cash.
  • Borqs Technologies, Inc. (NASDAQ: BRQS) gained 33.7 percent to $7.62.
  • Global Blood Therapeutics, Inc. (NASDAQ: GBT) shares climbed 29.2 percent to $40.74. Global Blood announced Monday that the FDA has agreed to allow filing for its late-stage sickle cell disease, or SCD, candidate Voxelotor under an accelerated approval pathway. The company said it would submit a new drug application, or NDA, for the pipeline asset under the pathway.
  • Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) shares gained 16.5 percent to $29.16 after the company's phase 2 study of Tradipitant met its primary endpoint and most secondary endpoints.
  • Clovis Oncology, Inc. (NASDAQ: CLVS) rose 15.4 percent to $19.86.
  • Biohaven Pharmaceutical Holding Company Ltd. (NASDAQ: BHVN) gained 15.4 percent to $39.22 after reporting positive Phase 3 results with rimegepant zydis orally dissolving tablet for the acute treatment of migraine.
  • Osmotica Pharmaceuticals plc (NASDAQ: OSMT) climbed 12.7 percent to $8.88.
  • Karyopharm Therapeutics Inc. (NASDAQ: KPTI) rose 12.6 percent to $11.71 after reporting positive top-line Phase 2b SADAL data for selinexor in patients with diffuse large B-cell lymphoma at the American Society of Hematology 2018 Annual Meeting.
  • argenx SE (NASDAQ: ARGX) rose 12.2 percent to $108.57 after Janssen affiliate Cilag GmbH International disclosed a worldwide collaboration and license agreement with Argenx for cancer immunotherapy cusatuzumab.
  • CASI Pharmaceuticals, Inc. (NASDAQ: CASI) gained 11.3 percent to $4.82 after reporting China market approval of Melphalan Hydrochloride for injection.
  • Laredo Petroleum, Inc. (NYSE: LPI) climbed 11.3 percent to $4.86.
  • Wynn Resorts, Limited (NASDAQ: WYNN) rose 10.4 percent to $120.80.
  • Tribune Media Company (NYSE: TRCO) rose 9.9 percent to $44.255 after Nexstar Media Group Inc (NASDAQ: NXST) announced plans to acquire the company for $46.50 per share.
  • Karyopharm Therapeutics Inc. (NASDAQ: KPTI) shares climbed 9.6 percent to $11.40.
  • Crescent Point Energy Corp. (NYSE: CPG) gained 9.4 percent to $3.24.
  • Cenovus Energy Inc. (NYSE: CVE) shares jumped 9 percent to $8.04.
  • Chart Industries, Inc. (NASDAQ: GTLS) rose 8.3 percent to $68.830. Evercore ISI Group upgraded Chart Industries from In-Line to Outperform.
  • China Internet Nationwide Financial Services Inc. (NASDAQ: CIFS) shares rose 8 percent to $1.76.
  • ZAGG Inc (NASDAQ: ZAGG) gained 7.8 percent to $10.83.
  • The Timken Company (NYSE: TKR) climbed 6.6 percent to $42.80. Bank of America upgraded Timken from Neutral to Buy.
  • Seadrill Limited (NYSE: SDRL) shares rose 6.5 percent to $14.520 after dropping 7.40 percent on Friday.
  • CLPS Incorporation (NASDAQ: CLPS) gained 6.5 percent to $5.88.
  • RadiSys Corporation (NASDAQ: RSYS) rose 6.2 percent to $1.71 after the company reported the CFIUS clearance related to its acquisition of Reliance Industries.
  • Noodles & Company (NASDAQ: NDLS) climbed 6.2 percent to $8.40. RBC Capital upgraded Noodles & Co from Sector Perform to Outperform.
  • New Age Beverages Corporation (NASDAQ: NBEV) rose 6.1 percent to $4.91 after the company announced plans to acquire Morinda Holdings, Inc. for $75 million in cash and $10 million in stock.

 

Check out these big penny stock gainers and losers

Losers

  • Sienna Biopharmaceuticals, Inc. (NASDAQ: SNNA) shares tumbled 30.7 percent to $7.01 after reporting top-line results from a Phase 2b study of SNA-120.
  • Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) shares fell 25.8 percent to $3.85 after the company filed for a $34M stock and warrant offering.
  • Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) fell 23.3 percent to $2.9465 after rising 37.14 percent on Friday.
  • Hexindai Inc. (NASDAQ: HX) shares dropped 19.7 percent to $3.54 following Q2 results. Hexindai posted a Q2 loss of $0.36 per share on sales of $3.62 million.
  • Aphria Inc. (NYSE: APHA) declined 19.6 percent to $6.35 after Reuters reported that 2 research firms issued negative reports on the stock.
  • Tel-Instrument Electronics Corp. (NYSE: TIK) fell 19.5 percent to $3.1155 after surging 57.96 percent on Friday.
  • Sphere 3D Corp. (NASDAQ: ANY) dropped 13.7 percent to $4.54.
  • UTStarcom Holdings Corp. (NASDAQ: UTSI) shares declined 12.4 percent to $3.1269.
  • Realm Therapeutics Plc (NASDAQ: RLM) shares tumbled 11.7 percent to $2.63.
  • Xcel Brands, Inc. (NASDAQ: XELB) fell 11.5 percent to $1.8313.
  • Sears Hometown and Outlet Stores, Inc. (NASDAQ: SHOS) dropped 11.4 percent to $1.87.
  • Arlo Technologies, Inc. (NYSE: ARLO) shares declined 11.4 percent to $10.65. Arlo Technologies expects Q4 sales of $125 million to $130 million.
  • Centrus Energy Corp. (NYSE: LEU) shares fell 10.6 percent to $2.5037.
  • Magenta Therapeutics, Inc. (NASDAQ: MGTA) dropped 10 percent to $8.80.
  • Trillium Therapeutics Inc. (NASDAQ: TRIL) fell 9.6 percent to $2.72 following an update on its intratumoral TTI-621 program at the American Society of Hematology 60th Annual Meeting.
  • Ocular Therapeutix, Inc. (NASDAQ: OCUL) dropped 9.6 percent to $6.02. Cantor Fitzgerald reiterated Overweight rating on Ocular Therapeutics following the FDA approval of DEXTENZA.
  • Onconova Therapeutics, Inc. (NASDAQ: ONTX) fell 8.1 percent to $3.9889 after highlighting results from Phase 2 trial of oral rigosertib in combination with azacitidine in myelodysplastic syndromes at 2018 ASH Annual Meeting.
  • Alliqua BioMedical, Inc. (NASDAQ: ALQA) shares dipped 7.8 percent to $2.5440.
  • bluebird bio, Inc. (NASDAQ: BLUE) fell 7.2 percent to $114.03. bluebird bio and Celgene Corporation (NASDAQ: CELG) presented initial Phase 1 data for multiple myeloma treatment candidate bb21217 at ASH 2018.
  • Xenetic Biosciences, Inc. (NASDAQ: XBIO) dipped 6.8 percent to $3.075.
 

Related Articles (AETI + ADIL)

View Comments and Join the Discussion!

Posted-In: LosersNews Movers & Shakers Intraday Update Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com